Pub. Date : 1998 Dec 1
PMID : 9916886
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. | Glatiramer Acetate | negative elongation factor complex member C/D | Homo sapiens |
| 2 | Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation. | Glatiramer Acetate | negative elongation factor complex member C/D | Homo sapiens |
| 3 | These results suggest that the beneficial clinical effects of Copaxone in MS patients may be attributed to changes in activation of T cell subsets and a shift from Th1 to Th2/Th3 cytokine profile, probably leading to Cop-1-driven mechanisms of bystander suppression. | Glatiramer Acetate | negative elongation factor complex member C/D | Homo sapiens |